India likely to extend price caps to more drugs


MUMBAI: The government of India is likely to raise the number of drugs deemed essential and subject to price caps, people directly involved in the process said.

A panel formed by India’s health ministry met for the first time yesterday to consider adding more drugs to the list of essential medicines, all of which would then come under price caps, one of the people said. The move would make the drugs more affordable in a country where 70% of the people live on less than US$2 a day.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , Business , India , pharmaceutical , drugs

   

Next In Business News

Capital markets key to boosting SME financing, promoting innovation
SC aims to grow MSME, MTC capital market fundraising to RM40bil by 2028
Ringgit slips as Fed minutes weigh on demand
Hartalega to see sequential growth as glove demand picks up
SingTel annual profit more than halves on US$2.3bil impairment charge
South Korea extends rate pause, raises growth outlook
FBM KLCI opens lower as Fed minutes signal hawkish mood
Singapore Q1 GDP up 2.7% y/y, above market forecast
Trading ideas: TNB, Lagenda, Apollo, George Kent, Magma, Advancecon, Hong Seng, Pos, TSR, Sunway
Opportunities in Kazakhstan and Uzbekistan

Others Also Read